Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.38 |
---|---|
High | 2.53 |
Low | 2.23 |
Bid | 2.44 |
Offer | 2.45 |
Previous close | 2.38 |
Average volume | 356.37k |
---|---|
Shares outstanding | 58.97m |
Free float | 52.19m |
P/E (TTM) | -- |
Market cap | 140.34m USD |
EPS (TTM) | -1.30 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 18:26 GMT.
More ▼
- Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
- Seer to Participate in Upcoming November Investor Conferences
- Seer Reports Third Quarter 2024 Financial Results
- Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
- Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
- Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024
- Seer to Report Third Quarter 2024 Financial Results on November 6, 2024
- Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Seer Appoints Nicolas Roelofs to its Board of Directors
- Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
More ▼